About us
Services & Solutions
Chemistry DMPK Discovery Biology Oncology Pharmacology Biologics
Medicinal Chemistry Computational Chemistry Synthetic Chemistry Analytical Chemistry Scale Up Chemistry
In Vivo PK and TK In Vitro ADME Bioanalytical Service Exploratory Toxicity In Rodents, Dogs and Monkeys Large Molecules Capabilities Bioanalytical Instruments
Biochemical Assays Cellular Assays Protein Science Assay Technologies Biophysics SPR Safety Pharmacology Screening Services Key Instruments
PDX CDX Orthotopic Models Syngeneic Models Humanized Mouse Models CAR-T and CAR-NK Mouse Models In Vitro Assays
Immunology Inflammation Metabolic NASH Respiratory Neuroscience
Systematic Antibody Discovery Service
Process R&D Scale Up Synthesis DS Manufacturing
Flow Chemistry Sugar Chemistry Peptide Chemistry Preparative Purification Capacity Process Safety Assessment
Synthetic and Scale Up Chemistry Parallel Synthesis
Flow Chemistry Kilo and Pilot Scale Production RSM and Intermediates Manufacturing QA EHS
Pre-Formulation Formulation, Analytical and Process Development Drug Product Manufacturing
Bioavailability Enhancement Modified Release
Commercial Manufacturing
Platforms
News & Resources
Careers
Contact us
CN EN
×
news
Company News Events Insights Webinars Virtual Tours
BioDuro Announces Cooperation Agreement with Porton Pharma Solutions
Beijing, January 30, 2018 – PR Newswire – BioDuro LLC, a leading global life sciences contract research, development and manufacturing organization announced today a cooperation agreement with Porto
January 30, 2018
Sundia congratulates NHRI for DBPR114 IND approval in US & Taiwan
Shanghai, November 7, 2017 – Sundia would like to congratulate its partner, the National Health Research Institutes (NHRI) in Taiwan, for successfully receiving both US and Taiwan IND approvals for DBPR114 on July 20th and Nov 7t
November 07, 2017
Sundia’s VP, Dr. Russell Dahl was invited to attend SAPA-GP 15th Annual Conference
Shanghai, June 23, 2017 – The ‘SAPA-GP 15th Annual Conference’, one of the most premier pharma conference organized by SAPA-GP (Sino-American Pharmaceutical Professionals Association), was held in Philadelphia, PA, USA from Ju
June 23, 2017
Sundia Receives 2016 Outstanding Contribution Enterprise Award by Shanghai Pudong Modern Service Industry Association
Shanghai, January 18, 2017 – We are pleased to announce that Sundia MediTech Company, a leading pre-clinical contract research organization (“CRO”), was awarded the 2016 Outstanding Contribution Enterprise Award by the Shanghai P
January 18, 2017
New Strategies Required to Meet Changing Needs in the Analytical Services Market
The pharmaceutical analytical services market is growing, but the competition is heating up. (Bio)pharmaceutical companies rely on analytical service providers to provide high-quality support for core
December 31, 2016
Total 84 12...91011121314151617
NASH Webinar Coming Soon
Register Today! This online event "Unleashing Innovation: A New Obesogenic NASH Model with High Clinically Translational Power" translates NASH/NAFLD research to clinic with better representative data, faster.
View more
Subscribe to BioDuro-Sundia
Receive our newsletter and information on upcoming events
Your trusted partner from drug discovery and
development to commercialization

Home

About us

Services & Solutions

Platforms

News & Resources

Careers

Contact us

Explore

Discovery

Drug Substance

Drug Product

© 2023 BioDuro-Sundia. All rights reserved
Terms of Use Privacy Policy
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all